Journal of Nuclear Medicine February 2026, jnumed.125.270677; DOI: https://doi.org/10.2967/jnumed.125.270677 ...

Journal of Nuclear Medicine July 2026, jnumed.126.265448e; DOI: https://doi.org/10.2967/jnumed.126.265448e ...

Quantitative analysis has been applied extensively to image processing and interpretation in nuclear cardiology to improve disease diagnosis and risk stratification. This is Part 2 of a two-part ...

The incidence of androgen receptor (AR)–negative (AR−) prostate cancer, including aggressive neuroendocrine prostate cancer (NEPC), has more than doubled in the last decade, but its timely diagnosis ...

Learning Objectives 1. To review the epidemiology, pathology, and clinical presentation of calciphylaxis. 2. To review the typical bone scan and plain x-ray findings. 3. To examine the role SPECT-CT ...

Heart failure remains a major source of late morbidity and mortality after myocardial infarction (MI). The temporospatial presence of activated fibroblasts in the injured myocardium predicts the ...

The diagnosis and surveillance of clear cell renal cell carcinoma (ccRCC) remains a clinical challenge. The high and specific expression of the cluster of differentiation 70 (CD70) in ccRCC makes it a ...

Journal of Nuclear Medicine October 2025, jnumed.124.269188; DOI: https://doi.org/10.2967/jnumed.124.269188 ...

Journal of Nuclear Medicine June 2025, 66 (supplement 1) 251562; ...

The recently released Biograph mMR is the first commercially available integrated whole-body PET/MR scanner. There are considerable advantages to integrating both modalities in a single scanner that ...

Prostate-specific membrane antigen (PSMA), expressed by most prostate carcinomas (PCa), is a promising target for PCa imaging. The application of PSMA-specific 18F-labeled PET probes such as ...

Journal of Nuclear Medicine October 2024, jnumed.124.268363; DOI: https://doi.org/10.2967/jnumed.124.268363 metastatic castration-resistant prostate cancer prostate ...